Bristol-Myers Squibb Company
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 18.70 |
| 52 Week High | 30.23 |
| 52 Week Low | 16.00 |
| Avg. Daily Vol. (Mil) | 13.59 |
| Beta (3 year) | 1.03 |
| Share Related Items | |
| Mkt Cap (Mil) | 37,018.82 |
| Shares Out (Mil) | 1,979.62 |
| Float (Mil) | 1,978.52 |
| Dividend Information | |
| Yield % | 6.60 |
| Annual Dividend | 1.24 |
| Payout Ratio | 108.00 |
| Financial Strength | |
| Quick Ratio | 1.00 |
| Current Ratio | 1.50 |
| LT Debt/ Equity | 0.56 |
| Total Debt / Equity | 0.73 |
| Valuation Ratios | |
| Price Earnings | 17.20 |
| Price/Sales | 1.82 |
| Price/Book | 3.44 |
| Price/Cash Flow | 11.90 |
| Per Share Data | |
| Earnings | 1.09 |
| Sales | 10.27 |
| Book Value | 5.44 |
| Cash Flow | 1.57 |
| Business Summary | |
|---|---|
| The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products. | |
| General Information | |
| 345 Park Avenue
New York, NY 10154 |
|
| www.bms.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 42000 | |
| CEO: James M. Cornelius | |
| Short Interest | |
| Current Month (Mil) | 17.92 |
| Previous Month (Mil) | 14.86 |
| Short Interest Ratio (Days) | 1.20 |
| Management Effectiveness | |
| Return on Equity | 20.40 |
| Return on Assets | 7.80 |
| Return on Investments | 13.10 |
| Profitability | |
| Gross Margin | 72.00 |
| EBIT Margin | 21.30 |
| Profit Margin | 10.80 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas